Dr. Odeth Barrett-Campbell, MD

Dr. Barrett-Campbell practices at Beckley ARH Hospital in Beckley, West Virginia, part of ARH.

Dr. Barrett-Campbell's NPI, 1306297999, was assigned on June 25, 2016. Dr. Barrett-Campbell holds Kentucky license 31513.

Dr. Barrett-Campbell's primary practice is Beckley ARH Hospital, at 306 Stanaford Road, Beckley, WV 25801 in Raleigh County. The practice phone is (304) 255-3000.

Dr. Barrett-Campbell's primary practice is Beckley ARH Hospital in Beckley, West Virginia, part of ARH. Dr. Barrett-Campbell is also affiliated with Raleigh General Hospital. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Barrett-Campbell to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barrett-Campbell practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Barrett-Campbell's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Barrett-Campbell is licensed in Kentucky.

CMS data shows 449 Medicare services from Dr. Barrett-Campbell across 7 procedure codes in 2024, for 110 Medicare patients. Medicare paid $25,043 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Barrett-Campbell in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barrett-Campbell's median patient age at 64, with 63% women.

In 2024, Dr. Barrett-Campbell wrote 306 Medicare Part D claims for 46 patients. 55% of them were for generic drugs. CMS names the drug for 132 of them, across 8 drugs with 11 or more claims each, at $683,895 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Barrett-Campbell for performance year 2024, reported through an alternative payment model (APM). Dr. Barrett-Campbell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barrett-Campbell as offering telehealth.

CMS Open Payments shows 150 general payments to Dr. Barrett-Campbell from 38 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 83% of the total. Astellas Pharma US Inc paid the most, $257.